LWM
TMO icon

LeConte Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

LeConte Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Buy
449
+25
+6% +$13.6K 0.14% 132
2025
Q4 		$246K Sell
424
-35
-8% -$19.8K 0.16% 102
2025
Q3 		$223K Buy
+459
New +$214K 0.15% 115

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LeConte Wealth Management's TMO Position: Q1 2026 in Review

LeConte Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 5.9% in Q1 2026, buying an estimated $13.6K and bringing the position to 449 shares worth $221K. The position accounts for 0.14% of the portfolio, ranked #132.

LeConte Wealth Management first reported a position in TMO in Q3 2025 and has held it in 3 quarters since. The position peaked at $246K in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • LeConte Wealth Management held 449 shares of Thermo Fisher Scientific worth $221K as of Q1 2026.
  • LeConte Wealth Management bought 25 Thermo Fisher Scientific shares in Q1 2026, an estimated $13.6K.
  • Thermo Fisher Scientific made up 0.14% of LeConte Wealth Management's portfolio in Q1 2026, its #132 holding.
  • LeConte Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 3 quarters since.
  • LeConte Wealth Management's Thermo Fisher Scientific position peaked at $246K in Q4 2025.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on LeConte Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.